These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31345283)

  • 1. Corrigendum to "Peripheral IntravenousVolume Analysis (PIVA) for Quantitating Volume Overload in Patients Hospitalized with Acute Decompensated Heart Failure-A Pilot Study" Journal of Cardiac Failure Vol. 24 No. 8, pp. 525-532.
    Miles M; Alvis BD; Hocking K; Baudenbacher F; Guth C; Lindenfeld J; Brophy C; Eagle S
    J Card Fail; 2019 Jul; 25(7):579-581. PubMed ID: 31345283
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral Intravenous Volume Analysis (PIVA) for Quantitating Volume Overload in Patients Hospitalized With Acute Decompensated Heart Failure-A Pilot Study.
    Miles M; Alvis BD; Hocking K; Baudenbacher F; Guth C; Lindenfeld J; Brophy C; Eagle S
    J Card Fail; 2018 Aug; 24(8):525-532. PubMed ID: 29777760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral Venous Waveform Analysis for Detecting Hemorrhage and Iatrogenic Volume Overload in a Porcine Model.
    Hocking KM; Sileshi B; Baudenbacher FJ; Boyer RB; Kohorst KL; Brophy CM; Eagle SS
    Shock; 2016 Oct; 46(4):447-52. PubMed ID: 27070329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction" Journal of Cardiac Failure, Vol. 22, No. 6, June 2016, pp. 423-432.
    Matsue Y; Suzuki M; Torii S; Yamaguchi S; Fukamizu S; Ono Y; Fujii H; Kitai T; Nishioka T; Sugi K; Onishi Y; Noda M; Kagiyama N; Satoh Y; Yoshida K; Goldsmith SR
    J Card Fail; 2016 Nov; 22(11):941. PubMed ID: 27481596
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America" Journal of Cardiac Failure Vol. 25 No. 8, pp. 584-619.
    Dunlay SM; Givertz MM; Aguilar D; Allen LA; Chan M; Desai AS; Deswal A; Dickson VV; Kosiborod MN; Lekavich CL; Mccoy RG; Mentz RJ; Pina IL;
    J Card Fail; 2019 Oct; 25(10):851. PubMed ID: 31444147
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripheral i.v. analysis (PIVA) of venous waveforms for volume assessment in patients undergoing haemodialysis.
    Hocking KM; Alvis BD; Baudenbacher F; Boyer R; Brophy CM; Beer I; Eagle S
    Br J Anaesth; 2017 Dec; 119(6):1135-1140. PubMed ID: 29028929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum to "Non-Invasive Lung Impedance-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (Impedance-HF Trial)": Journal of Cardiac Failure Vol. 22 No. 9, pp. 713-722.
    Shochat MK; Shotan A; Blondheim DS; Kazatsker M; Dahan I; Asif A; Rozenman Y; Kleiner I; Weinstein JM; Frimerman A; Vasilenko L; Meisel SR
    J Card Fail; 2017 Jun; 23(6):512-513. PubMed ID: 28571729
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).
    Voors AA; Dittrich HC; Massie BM; DeLucca P; Mansoor GA; Metra M; Cotter G; Weatherley BD; Ponikowski P; Teerlink JR; Cleland JG; O'Connor CM; Givertz MM
    J Am Coll Cardiol; 2011 May; 57(19):1899-907. PubMed ID: 21545947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Driving Pulseless: A driving survey of patients with LVADs and their providers" Journal of Cardiac Failure Vol. 25 No. 9, pp. 220-221.
    Seif E; Sherazi S; Bravo-Jaimes K; Gosev I; Cheyne C; Alexis JD
    J Card Fail; 2019 Jul; 25(7):582. PubMed ID: 31160143
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of Blood Pressure and Heart Rate in Acute Decompensated Heart Failure with Volume Overload.
    Kocyigit D; Gurses KM; Yalcin MU; Tokgozoglu L
    Curr Pharm Des; 2017; 23(31):4609-4619. PubMed ID: 28552064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.
    Weatherley BD; Cotter G; Dittrich HC; DeLucca P; Mansoor GA; Bloomfield DM; Ponikowski P; O'Connor CM; Metra M; Massie BM;
    J Card Fail; 2010 Jan; 16(1):25-35. PubMed ID: 20123315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac troponin and outcome in acute heart failure.
    Peacock WF; De Marco T; Fonarow GC; Diercks D; Wynne J; Apple FS; Wu AH;
    N Engl J Med; 2008 May; 358(20):2117-26. PubMed ID: 18480204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the heterogeneity in volume overload and fluid distribution in decompensated heart failure is key to optimal volume management: role for blood volume quantitation.
    Miller WL; Mullan BP
    JACC Heart Fail; 2014 Jun; 2(3):298-305. PubMed ID: 24952698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute decompensated heart failure and the cardiorenal syndrome.
    Liang KV; Williams AW; Greene EL; Redfield MM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S75-88. PubMed ID: 18158481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large volume ultrafiltration for acute decompensated heart failure using standard peripheral intravenous catheters.
    Dahle TG; Blake D; Ali SS; Olinger CC; Bunte MC; Boyle AJ
    J Card Fail; 2006 Jun; 12(5):349-52. PubMed ID: 16762797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study.
    Cleland JG; Chiswell K; Teerlink JR; Stevens S; Fiuzat M; Givertz MM; Davison BA; Mansoor GA; Ponikowski P; Voors AA; Cotter G; Metra M; Massie BM; O'Connor CM
    Circ Heart Fail; 2014 Jan; 7(1):76-87. PubMed ID: 24281134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Kidney Injury in Pediatric Acute Decompensated Heart Failure.
    Medar SS; Hsu DT; Lamour JM; Aydin SI
    Pediatr Crit Care Med; 2015 Jul; 16(6):535-41. PubMed ID: 25856473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound guidance allows faster peripheral IV cannulation in children under 3 years of age with difficult venous access: a prospective randomized study.
    Benkhadra M; Collignon M; Fournel I; Oeuvrard C; Rollin P; Perrin M; Volot F; Girard C
    Paediatr Anaesth; 2012 May; 22(5):449-54. PubMed ID: 22409596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure.
    Fonarow GC;
    Rev Cardiovasc Med; 2003; 4 Suppl 7():S21-30. PubMed ID: 14668697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.